Pharmanza (India) Private Limited, a active private limited company, was established on 15 January 2009 in Khambhat, Gujarat, India. Engaging in animal pharmaceuticals & healthcare within the manufacturing sector, it holds CIN: U24230GJ2009PTC055895. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹2.50 Cr and a paid-up capital of ₹2.50 Cr.
It upholds a compliant status. Employing 119 professional, Its leadership includes Lal Lachhmandas Hingorani (Director), Bhupendrabhai Jivabhai Patel (Managing Director), Hardik Ravindrabhai Patel (Whole-Time Director). Past directors included Vijaykumar Champaklal Shah, Bhupendrabhai Jivabhai Patel, Ravindrabhai Purshottambhai Patel. It holds ₹5.17 Cr open charges and ₹2.09 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 70/1 G.I.D.C Estate Kansari, Khambhat, Gujarat, 388630.
U24230GJ2009PTC055895
055895
15 January 2009
₹2.50 Cr
₹2.50 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Pharmanza (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Lal Lachhmandas Hingorani | Director | 15 Jan 2009 | Current |
| Bhupendrabhai Jivabhai Patel | Managing Director | 15 Jan 2009 | Current |
| Hardik Ravindrabhai Patel | Whole-Time Director | 15 Jan 2009 | Current |
| Kruti Viral Shah | Director | 10 Nov 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 29 Oct 2023 | Past |
| Pramod Abcsdd | Director | 01 Apr 2013 | Past |
| Pramod Abcsdd | Additional Director | 01 Apr 2013 | Past |
| Pramod Abcsdd | Director | 01 Apr 2013 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Pharmanza (India) Private Limited, for the financial year ended 2024, experienced Minor drop in revenue, with a 0.7% decrease. The company also saw a substantial improvement in profitability, with a 224.82% increase in profit. The company's net worth Soared by an impressive increase of 18.05%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Pharmanza (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹51,666,000.00
₹20,850,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Aug 2010 | Bank Of India | ₹5.17 Cr | Open |
| 09 Feb 2018 | Others | ₹2.10 M | Satisfied |
| 24 Jun 2009 | Indusind Bank Limited | ₹7.25 M | Satisfied |
| 05 Feb 2009 | The Dharmaj People Cooperative Bank Limited | ₹1.15 Cr | Satisfied |
Explore comprehensive loan charge details -
Pharmanza (India) has a workforce of 119 employees as of Mar 11, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Pharmanza (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmanza (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Pharmanza (India) Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
Pharmanza (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.
Kruti Viral Shah was appointed as a Director was appointed as a Director on 10 Nov 2023 & has been associated with this company since 2 years 2 months . was recorded as a recent event.
A charge registered on 09 Feb 2018 via Charge ID 100190808 with Others was fully satisfied on 09 Sep 2022. was recorded as a recent event.
Progress on A charge with Bank Of India of Rs. 5.17 Cr registered on 30 Aug 2010 with Charge ID 10242403 was modified on 29 Jun 2020. was documented.
A charge with Others amounted to Rs. 0.21 Cr with Charge ID 100190808 was registered on 09 Feb 2018. was recorded as a recent event.
The CIN of Pharmanza (India) Private Limited is U24230GJ2009PTC055895.
Pharmanza (India) Private Limited is headquartered at 70/1 G.I.D.C Estate Kansari, Khambhat, Gujarat, 388630.
Pharmanza (India) Private Limited was incorporated on 15 January 2009.
The current directors of Pharmanza (India) Private Limited are
The primary industry of Pharmanza (India) Private Limited is Manufacturing.
Pharmanza (India) Private Limited is unlisted.
The authorized capital of Pharmanza (India) Private Limited is ₹2.50 Cr, and the paid-up capital is ₹2.50 Cr.
The compliance status of Pharmanza (India) Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX